Oral Nano-Delivery Systems for Colon Targeting Therapy

Area of Science:

• Pharmacology
• Biotechnology
• Nanomedicine

Background:

• Targeted drug delivery enhances therapeutic efficacy and reduces systemic toxicity by enabling localized treatment.
• Colon targeting delivery is crucial for treating colon diseases, including inflammatory bowel disease and colon cancer, by increasing local drug concentrations.
• Nanotechnology offers a novel approach for colon targeting, protecting drugs from the gastrointestinal environment and concentrating them at disease sites.

Purpose of the Study:

• To comprehensively review recent advancements in colon targeting drug delivery.
• To discuss the pathophysiological changes in diseased colon sites relevant to drug delivery.
• To identify and analyze the obstacles hindering effective drug delivery to the colon.

Main Methods:

• Literature review of recent progress in colon targeting drug delivery.
• Analysis of pathophysiological changes in diseased colons.
• Evaluation of challenges and opportunities in colon drug delivery systems.

Main Results:

• Nanotechnology-based formulations show significant potential for oral colon targeting delivery.
• Nano-systems can protect drugs and improve local concentrations at the disease site.
• Recent advancements have demonstrated the efficacy of various nano-systems for colon disease therapy.

Conclusions:

• Colon targeting drug delivery, particularly using nanotechnology, holds great promise for treating colon diseases.
• Understanding colon pathophysiology is key to overcoming drug delivery obstacles.
• Further research into nano-based systems can optimize therapeutic outcomes for colon conditions.